You searched for "Dry eye"
Long-term meibomian gland function following a single thermal pulsation treatment
1 December 2013
| Kwesi Amissah-Arthur
|
EYE - Cornea, EYE - General
|
LipiFlow thermal pulsation system, dry eye, meibomian gland dysfunction
Dry eyes secondary to blepharitis and or meibomian gland dysfunction, though extremely common, is an annoyingly difficult condition to treat for several patients. Part of this difficulty lies in the inability of most patients to follow intensive and often times...
Conjunctivochalasis and aqueous tear deficiency – which one causes symptoms?
This review sought to determine whether conjunctivochalasis (CCh) obliterates the fornix tear reservoir and thus mimics aqueous tear deficiency (ATD). Patients were divided into two groups, with aqueous tear deficiency (CCh +ATD) or without (CCh –ATD), based on results of...From dry eyes to glaucoma: How the menopause impacts your eyes and what to do about it, according to an optician
Menopause, much like entering puberty, comes with hormonal disruptions that change a woman's body and behaviour. Some of the first visible side effects are hot flushes, weight gain, and acne, accompanied by behavioural symptoms like mood swings, insomnia, and brain...The management of possibly progressive pterygium
1 February 2015
| Amit Patel, Peter McDonnell, M Quinlan
|
EYE - Cornea
A 43-year-old Sudanese male patient is referred by his GP with a fleshy lesion encroaching the nasal cornea for the last six months. History Make note of: risk factors, i.e. UV exposure and ocular irritation - history of living in...
Revealed: The growing crisis of workplace-related eye injuries
5 March 2025
|
industry, NuVision, occupational health, occupational safety, eye health, patient information
Nearly half of UK workers believe their job puts their eye health at risk, yet are businesses overlooking this critical issue? New survey findings commissioned by NuVision Biotherapies highlight a rising yet often ignored concern in workplace health; eye injuries...
What's trending Oct/Nov 2023
4 October 2023
| Amit Dhalla
|
EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Hello A big hello to those reading. It’s my absolute pleasure to take on the mantel of section editor of the...
10 daily habits damaging your eyesight and changes you can make to remedy against them
15 March 2023
Following World Glaucoma Day on 12 March this year, it is vital that the longevity of our vision is always a priority. However, many of our daily habits contribute to the onset of glaucoma and vision loss.
My top five: Trinkets of fact or fiction
3 June 2024
| Nishant Aggarwal
|
EYE - General
Trinkets of adult wisdom are often delivered to children alongside warnings of catastrophic outcomes. In this article we present five ‘facts’ about eye health and vision and ask the question: to what extent are these ideas backed up by literature?...
My Top Five: Trinkets of fact or fiction
3 June 2024
| Nishant Aggarwal
|
EYE - General
Trinkets of adult wisdom are often delivered to children alongside warnings of catastrophic outcomes. In this article we present five ‘facts’ about eye health and vision and ask the question: to what extent are these ideas backed up by literature?...
21st Century retinal laser treatment in the anti-VEGF era
1 June 2017
| John Awad, Prasad Rao
|
EYE - Vitreo-Retinal
In today’s world, macular laser treatment has a vital role in the treatment of diabetic macular oedema (DMO). DMO is one of the most common causes of visual impairment. Despite expensive intravitreal treatment courses of anti-VEGF, many will agree that...
Regulatory drug evaluations and expedited review initiatives: EU and US perspectives
1 April 2016
| Rod McNeil
|
EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
